Royal Bank of Canada’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,324
| Closed | -$46K | – | 7289 |
|
|
2024
Q1 | $46K | Sell |
1,324
-14,669
| -92% | -$510K | ﹤0.01% | 5138 |
|
|
2023
Q4 | $607K | Buy |
15,993
+10,812
| +209% | +$410K | ﹤0.01% | 3609 |
|
|
2023
Q3 | $95K | Buy |
5,181
+1,821
| +54% | +$33.4K | ﹤0.01% | 4938 |
|
|
2023
Q2 | $87K | Buy |
3,360
+1,135
| +51% | +$29.4K | ﹤0.01% | 5006 |
|
|
2023
Q1 | $41K | Sell |
2,225
-2,899
| -57% | -$53.4K | ﹤0.01% | 5346 |
|
|
2022
Q4 | $126K | Buy |
5,124
+4,384
| +592% | +$108K | ﹤0.01% | 4818 |
|
|
2022
Q3 | $13K | Buy |
740
+191
| +35% | +$3.36K | ﹤0.01% | 5835 |
|
|
2022
Q2 | $6K | Sell |
549
-1,551
| -74% | -$17K | ﹤0.01% | 6154 |
|
|
2022
Q1 | $47K | Sell |
2,100
-4,053
| -66% | -$90.7K | ﹤0.01% | 5668 |
|
|
2021
Q4 | $269K | Buy |
6,153
+3,146
| +105% | +$138K | ﹤0.01% | 4536 |
|
|
2021
Q3 | $100K | Buy |
3,007
+691
| +30% | +$23K | ﹤0.01% | 5197 |
|
|
2021
Q2 | $65K | Buy |
2,316
+1,178
| +104% | +$33.1K | ﹤0.01% | 5377 |
|
|
2021
Q1 | $23K | Buy |
1,138
+562
| +98% | +$11.4K | ﹤0.01% | 5860 |
|
|
2020
Q4 | $19K | Buy |
576
+191
| +50% | +$6.3K | ﹤0.01% | 5547 |
|
|
2020
Q3 | $7K | Buy |
+385
| New | +$7K | ﹤0.01% | 5579 |
|